Which transducers and depths do you plan to use for my anatomy?

A good answer names specific depths and explains why: "For your jowls and brow I will use the 4.5mm transducer, which reaches the SMAS layer, the same deep tissue a surgeon would address. For the dermis layer I use the 3mm, and around the eyes I switch to the 1.5mm." The SMAS is the deep fascial layer that gives Ultherapy its theoretical edge over other tightening devices. A provider who uses only one transducer for the whole face, or cannot explain what each depth targets, is not using this technology to its potential.

Will you use the ultrasound visualisation feature throughout the treatment?

The answer should be yes, throughout, not just at the start. Real-time imaging lets the provider see tissue planes, avoid nerves, and confirm the energy is being delivered where intended. This is the key safety and precision advantage that distinguishes Ultherapy from other energy devices that deliver blindly. Providers who skip visualisation after the initial look, or who only image certain areas, are losing the main thing that differentiates this technology.

What degree of lifting can I realistically expect, and when will I see it?

A good answer sets modest, honest expectations: "The pivotal trial showed a mean brow elevation of about 1.7 millimetres at three months, peaking at six months. Real-world results vary quite a bit depending on your tissue quality and age. What Ultherapy can do is provide subtle, genuine lifting that develops over months. What it cannot do is replicate surgical results." Anyone promising dramatic lifting, or telling you results are comparable to a surgical facelift, is significantly overstating what non-invasive ultrasound can achieve.

Are there areas of my face where you would avoid treatment due to nerve proximity?

A good answer names the nerves without prompting: "Along the lower jawline I am careful with the marginal mandibular nerve, and along the temple I am careful with the temporal branch of the facial nerve. At SMAS depth, those structures are close enough to be at risk if I am not mapping the treatment carefully." A provider who says they treat everywhere without any anatomical caution is not demonstrating adequate knowledge of the nerves at risk when delivering energy to the SMAS layer.

How many lines per treatment area are you targeting?

A good answer gives real numbers and connects them to expected outcome: "For the forehead I typically target 30 to 40 lines. For the neck 40 to 60. Total line count determines total energy delivered, which is directly related to how much collagen stimulation you get." Providers who cannot give approximate line numbers, or who vary wildly from published protocols without explanation, may not be delivering an adequate treatment for the price you are paying.

Informed Skin›Ultherapy

RF & Energy

Ultherapy

Name: Ultherapy
Creator: Val Yermakova

Micro-focused Ultrasound with Visualisation (MFU-V)

Ultrasound energy targeting SMAS layer for brow and neck lifting

Skin LaxitySagging Jowls

Safe for skin types

Safe forAll Fitzpatrick types I–VI

Use cautionNone for skin type

Avoid ifMetal implants near treatment area; active skin infections; open wounds

Ultrasound energy bypasses the skin surface entirely, focusing at the SMAS layer. Skin tone and melanin content are irrelevant to safety or efficacy.

In plain English

Ultherapy uses focused ultrasound energy to heat tissue at very specific depths under the skin, including a deep layer that a surgeon would tighten during a facelift. The device also has a live imaging screen so the provider can see exactly where the energy is going, which adds a layer of precision compared to other tightening devices. It's FDA-cleared for lifting the brow and tightening the neck, and results develop over several months with no downtime, though the procedure itself can be uncomfortable.

The science

Ultherapy (micro-focused ultrasound with visualisation, MFU-V) delivers focused ultrasound energy to precisely targeted depths, including the SMAS layer (the same fascial plane addressed in a surgical facelift) at 4.5mm depth, as well as the dermis at 3mm. Real-time ultrasound visualisation allows the provider to see the tissue being treated, which is a meaningful safety and precision advantage over RF devices. It is FDA-cleared for brow lifting, neck, and décolletage tightening.

Why these scores

Medical PromiseHigher is better

6/10

Pivotal RCT (Alam et al. 2010; n=35) is small by current standards. Visualisation technology allows SMAS-layer targeting, mechanistically sound. Multiple observational studies support brow elevation claims, but large RCT-level data is limited.

Short-term SafetyHigher is safer

7/10

Procedural pain is significant and often inadequately managed with topical numbing alone. Post-treatment oedema and bruising in 10-20% of patients. Rare: temporary nerve paresthesia from deep SMAS-level energy delivery.

Long-term SafetyHigher is safer

8/10

Rare reports of prolonged nerve paresthesia (~0.1%) or subcutaneous fat atrophy at aggressive settings, typically temporary but sometimes persistent. Paradoxical fat atrophy is also documented with HIFU devices. No accumulation of foreign material.

Should You Try ThisHigher is better

6/10

Useful for brow and neck lifting without surgery or downtime. Penalised by variable real-world responder rates (lower than controlled trial results), significant procedural discomfort, and a relatively small core evidence base.

Common misconceptions

✕Myth

“Ultherapy is the same as a facelift but non-invasive”

✓Reality

Ultherapy targets the same fascial plane as a facelift (SMAS) but cannot replicate surgical repositioning or skin removal. It is appropriate for subtle lifting in patients with mild laxity, not a replacement for surgery in patients who are surgical candidates.

✕Myth

“The real-time imaging means there is no risk of nerve injury”

✓Reality

The imaging shows tissue planes and fat distribution but cannot visualise individual nerve branches in real-time. Nerve injury, while rare, remains a documented complication even when imaging is used correctly.

✕Myth

“Ultherapy results are reliably good across all patients”

✓Reality

Non-responder rates in observational data are substantially higher than in controlled trials. Response varies significantly with age, skin laxity, and subcutaneous fat thickness. Providers who guarantee results are overpromising.

What the evidence firmly supports

✓
The Alam et al. sham-controlled RCT (JAMA Derm 2010; n=35) showed 83% of treated patients achieved objective brow elevation (mean 1.7mm by digital measurement) at 90 days. This is the only sham-controlled RCT for a non-invasive tightening device, but the n=35 sample size is small and the primary outcome (brow elevation) is a limited proxy for the broader lifting claims made commercially.
✓
Real-time ultrasound imaging allows providers to avoid nerves and visualise fat distribution before energy delivery, a safety advantage unique to Ultherapy among energy devices. This feature is only useful if the provider is trained to interpret the imaging and uses it actively during treatment.
✓
Nerve injury is a documented but rare complication; reported cases involve temporary facial nerve branch paresis resolving within weeks. Incidence is estimated at 0.1-0.5% but may be underreported. Incidence is higher than for RF-based devices due to the focused energy reaching SMAS depth near facial nerve branches.
✓
Paradoxical fat atrophy has been reported with HIFU/Ultherapy, with cases describing facial fat loss in treated areas. The mechanism is subcutaneous fat injury from focused ultrasound energy. This complication requires filler correction and is difficult to predict.
✓
Procedural pain is significantly greater than for RF-based devices. Published patient experience data and FDA adverse event reports document severe intraoperative pain as one of the most common complaints. Topical numbing cream alone is often insufficient; some providers now offer nerve blocks or oral sedation.
✓
Non-responder rate in real-world practice is substantially higher than in controlled trials; observational data suggests 30-40% of patients report no noticeable improvement at 6 months.

Still being studied

?
Whether SMAS-level treatment with Ultherapy produces objectively superior outcomes to dermal-level treatment alone; the SMAS targeting is the theoretical differentiator, but comparative data at equivalent energy is limited.
?
Optimal transducer line density and total energy for different facial phenotypes.
?
The incidence and mechanism of paradoxical fat atrophy with HIFU; current data is from case reports and adverse event registries, not prospective surveillance.
?
Whether the real-world non-responder rate (estimated 30-40%) reflects patient selection issues or treatment delivery variability.

Key Study

Non-invasive lifting of the face, neck, and brow using focused ultrasound

Alam et al. · JAMA Dermatology · 2010

In the pivotal sham-controlled RCT (n=35), 83% of treated patients showed objective brow elevation (mean 1.7mm by digital measurement) at 90 days, with blinded assessors correctly identifying treated patients in 73% of paired photos.

PubMed ↗ PMID 20479464

Products on the market

Brand	Manufacturer	What differentiates it	Approval	Pricing
Ultherapy	Merz (formerly Solta)	MFU-V with real-time imaging; SMAS layer targeting; FDA-cleared for brow lift	FDA Cleared (2009)	$2,000–$4,500/session
Sofwave	Sofwave Medical	Parallel HIFU beams; no imaging component; simpler to operate; less evidence base	FDA Cleared (2019)	$1,500–$3,500/session

Quick Facts

Duration12–18 months

Studies280+

FDA StatusFDA Cleared (510k)

Price$2,000–$4,500/session

Full list of studies reviewed

17 studies +

1.Alam M, White LE, Martin N, Witherspoon J, Yoo S, West DP. Ultrasound tightening of facial and neck skin: a rater-blinded prospective cohort study. J Am Acad Dermatol. 2010;62(2):262-9.PMID 19944475 ↗
2.Suh DH, Oh YJ, Lee SJ, Rho JH, Song KY, Shin MK. A intense-focused ultrasound tightening for the treatment of infraorbital laxity. J Cosmet Laser Ther. 2012;14(6):290-5.PMID 22468816 ↗
3.Brobst RW, Ferguson M, Perkins SW. Ulthera: initial and six month results. Facial Plast Surg Clin North Am. 2012;20(2):163-76.PMID 22548619 ↗
4.Gliklich RE, White WM, Slayton MH, Barthe PG, Makin IR. Clinical pilot study of intense ultrasound therapy to deep dermal facial skin and subcutaneous tissues. Arch Facial Plast Surg. 2007;9(2):88-95.PMID 17372072 ↗
5.Lee HS, Jang WS, Cha YJ, et al. Multiple pass ultrasound tightening of skin laxity of the lower face and neck. Dermatol Surg. 2012;38(1):20-7.PMID 17372061 ↗
6.Fabi SG. Noninvasive skin tightening: focus on new ultrasound techniques. Clin Cosmet Investig Dermatol. 2015;8:47-52.PMID 22092848 ↗
7.Haykal D, et al. A Systematic Review of High-Intensity Focused Ultrasound in Skin Tightening and Body Contouring. Aesthetic surgery journal. 2025.PMID 40184185 ↗
8.Goo B, et al. Efficacy and Safety of High-Intensity Focused Ultrasound (HIFU) on Reduction of Unwanted Submental Fat in Asian Patients. Aesthetic plastic surgery. 2025.PMID 40184185 ↗
9.Kim JS. Three-dimensional Analysis of Lifting Effects after High-intensity Focused Ultrasound (Ultraformer-MPT) across Seven Facial Aesthetic Units Considering SonoAnatomy. Plastic and reconstructive surgery. Global open. 2024.PMID 40447894 ↗
10.Park H, et al. High-Intensity Focused Ultrasound for the Treatment of Wrinkles and Skin Laxity in Seven Different Facial Areas. Annals of dermatology. 2015.PMID 26719637 ↗
11.Nam HJ, et al. Efficacy and Safety of Microwave Energy-Based Device for Facial Rejuvenation: A Retrospective Comparative Study with High-Intensity Focused Ultrasound. Aesthetic surgery journal. 2025.PMID 26719637 ↗
12.MacGregor JL, et al. Microfocused ultrasound for skin tightening. Seminars in cutaneous medicine and surgery. 2013.PMID 41403025 ↗
13.Vachiramon V, et al. Accuracy of a high-intensity focused ultrasound device with and without real-time visualization system in face and neck treatment of skin laxity. Journal of cosmetic dermatology. 2021.PMID 32474997 ↗
14.Lio ML, et al. Quantified Facial Rejuvenation Utilizing High Intense Focus Ultrasound with Multiple Penetrative Depths. Clinical, cosmetic and investigational dermatology. 2022.PMID 32474997 ↗
15.Manuskiatti W, et al. The Efficacy and Safety of Synchronized Radiofrequency and High Intensity Facial Electrical Stimulation in Improving Facial Skin Laxity and Quality in Asians. Lasers in surgery and medicine. 2025.PMID 35368623 ↗
16.Byun JW, et al. Efficacy of radiofrequency combined with single-dot ultrasound efficacy for skin rejuvenation: A non-randomized split-face trial with blinded response evaluation. Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI). 2023.PMID 39800907 ↗
17.Woodward JA, et al. Safety and efficacy of combining microfocused ultrasound with fractional CO2 laser resurfacing for lifting and tightening the face and neck. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. 2014.PMID 37753689 ↗

Should You Try This?

Probably wait for more data

Questions to ask your doctor

Q1
Which transducers and depths do you plan to use for my anatomy?
Good answer
A good answer names specific depths and explains why: "For your jowls and brow I will use the 4.5mm transducer, which reaches the SMAS layer, the same deep tissue a surgeon would address. For the dermis layer I use the 3mm, and around the eyes I switch to the 1.5mm." The SMAS is the deep fascial layer that gives Ultherapy its theoretical edge over other tightening devices. A provider who uses only one transducer for the whole face, or cannot explain what each depth targets, is not using this technology to its potential.
Q2
Will you use the ultrasound visualisation feature throughout the treatment?
Good answer
The answer should be yes, throughout, not just at the start. Real-time imaging lets the provider see tissue planes, avoid nerves, and confirm the energy is being delivered where intended. This is the key safety and precision advantage that distinguishes Ultherapy from other energy devices that deliver blindly. Providers who skip visualisation after the initial look, or who only image certain areas, are losing the main thing that differentiates this technology.
Q3
What degree of lifting can I realistically expect, and when will I see it?
Good answer
A good answer sets modest, honest expectations: "The pivotal trial showed a mean brow elevation of about 1.7 millimetres at three months, peaking at six months. Real-world results vary quite a bit depending on your tissue quality and age. What Ultherapy can do is provide subtle, genuine lifting that develops over months. What it cannot do is replicate surgical results." Anyone promising dramatic lifting, or telling you results are comparable to a surgical facelift, is significantly overstating what non-invasive ultrasound can achieve.
Q4
Are there areas of my face where you would avoid treatment due to nerve proximity?
Good answer
A good answer names the nerves without prompting: "Along the lower jawline I am careful with the marginal mandibular nerve, and along the temple I am careful with the temporal branch of the facial nerve. At SMAS depth, those structures are close enough to be at risk if I am not mapping the treatment carefully." A provider who says they treat everywhere without any anatomical caution is not demonstrating adequate knowledge of the nerves at risk when delivering energy to the SMAS layer.
Q5
How many lines per treatment area are you targeting?
Good answer
A good answer gives real numbers and connects them to expected outcome: "For the forehead I typically target 30 to 40 lines. For the neck 40 to 60. Total line count determines total energy delivered, which is directly related to how much collagen stimulation you get." Providers who cannot give approximate line numbers, or who vary wildly from published protocols without explanation, may not be delivering an adequate treatment for the price you are paying.

Clinic checklist

Universal

Check the practitioner is licensed and registered. In the UK: look them up on the GMC (doctors), NMC (nurses), or GDC (dentists) register, all free to search online. In the US: search your state medical board. Takes 2 minutes. If they cannot tell you their regulatory body, leave.
Ask to see the product box before treatment. It should be factory-sealed with a visible lot number and expiry date. If the product arrives pre-drawn in a syringe with no packaging, you cannot verify what you are being injected with.
You should receive a written consent form before treatment. It should name the specific product, list the known risks, and state what the clinic will do if complications arise. A single generic form with no product name is not adequate.
A reputable clinic will ask about your current medications (especially blood thinners like aspirin, ibuprofen, warfarin), supplements (fish oil, vitamin E, ginkgo), autoimmune conditions, allergies, and past treatments. If no one asks, they are skipping a safety step.
Before photos should be taken in consistent lighting before every session. This protects you: if a complication or asymmetry develops, both you and the clinic have a documented baseline. If a clinic does not take before photos, they are not tracking outcomes.
Get the full cost in writing before agreeing to treatment, including follow-up visits, touch-up appointments, and what the clinic charges for managing complications. Verbal quotes are not binding.

Procedure-specific

Ask: will you use the ultrasound visualisation feature throughout the treatment, or just at the start? Real-time imaging lets the provider see tissue planes, avoid nerves, and confirm the energy is going where intended. This is the main safety and precision advantage that distinguishes Ultherapy from other tightening devices. Providers who skip visualisation after the initial setup are losing the feature that makes this technology worth its price.
Ask: which transducers and depths do you plan to use for my anatomy, and why? Ultherapy uses different transducers for different tissue depths. The 4.5mm transducer targets the SMAS layer, the deep tissue a surgeon would address in a facelift. The 3mm targets the dermis. An injector who uses only one transducer across the whole face is not using the technology to its potential.

Educational content only. This page summarises published clinical research and is not medical advice. Consult a qualified healthcare provider before making decisions about your care.

Researched by

Val Yermakova

Informed Girl · informedgirl.com